Correlation between faecal Calprotectin and Magnetic Resonance Imaging (MRI) in the evaluation of infl ammatory pattern in Crohn's disease

Clinica Terapeutica

Volumn 161, Issue SUPPL.2, 2011, Pages

  Zippi, M ^a   Al Ansari, N ^a   Siliquini, F ^a   Severi, C ^a   Kagarmanova, A ^a   Maffia, C ^a   Parlanti, S ^a   Garbarino, V ^a   Maccioni, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Crohn's disease; Faecal calprotectin; Inflammatory markers; MRI

Indexed keywords

CALGRANULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; FECES ANALYSIS; FEMALE; HUMAN; INFLAMMATION; INTESTINE WALL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN CONTENT; SCORING SYSTEM;

EID: 84859797773     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Roseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodological study. Scand J Gastroenterol 1992; 27:793-8
2. Summerton CB, Longlands MG, Wiener K, et al. Faecal calprotectin: a marker of infl ammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002; 14:841-5
3. Roseth AG, Aadland E, Jahnsen J, et al. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997; 58:176-80
4. Roseth AG, Schmidit PN, Fagerthol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with infl ammatory bowel disease. Scand J Gastroenterol 1999; 34 (1):50-4
5. Schreyer AG, Seitz J, Feuerbach F, et al. Modern imaging using computer tomography and magnetic resonance imaging for infl ammatory bowel disease (IBD). Infl amm Bowel Dis 2004; 10 (1):45-54, abd imag 2000
6. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity Index: National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-44
7. Best WR, Becktel JM, Singleton JW, et al. Rederived values of the eight coeffi cients of the Crohn's Disease activity Index (CDAI). Gastroenterology 1979; 77:843-6
8. Saverymutt SH. Clinical remission in Crohn's disease assessment using faecal 111In granulocyte excretion. Digestion 1986; 33:74-9
9. Costa F, Mumolo MG, Bellini M, et al. Role of faecal calprotectin as non-invasive marker of intestinal infl ammation. Dig Liv Dis 2003; 35 (9):642-7
10. Madsen SM, Thomsen HS, Munkholm P, et al. Infl ammatory bowel disease evalueted by low-fi eld magnetic resonance imaging. Comparision with endoscopy, 99mTc-HMPAO leukocyte scintigraphy, conventional radiography and surgery. Scand J Gastroenterol 2002; 37:307-16
11. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imag 2000; 25:219-28